Table 1 2009 Community Prescription Numbers
Total Page：16
File Type：pdf, Size：1020Kb
TABLE 1 2009 COMMUNITY PRESCRIPTION NUMBERS, TOGETHER WITH GOVERNMENT AND PATIENT COSTS FOR PBS LISTED DRUGS Table 1 includes an estimate of community prescription numbers for the 2009 calendar year, costs (government and patient contribution) for the items with a four digit PBS/RPBS code, together with the defined daily dose (DDD) where assigned. There is no cost information available for items with a five digit Amfac drug code. Table 1 excludes the presentation of information on any item with an estimated community use of less than 110 prescriptions in 2009. The prescription items are arranged by ATC code on generic name, and by form and strength using either the PBS drug code (4 digit plus alpha) or, for non-PBS items, the Amfac drug code (5 digit). Note that in this edition, “Item type” has been added to distinguish between PBS drug code and non-PBS drug code, for instance, P refers to PBS drug code and A refers to Amfac drug code. Note that Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs) 2010 is used in all statistics published in this edition (refer to WHO collaborating Centre for Drug Statistics Methodology, ATC classification index with DDDs 2010). An index by second level of the ATC classification follows: ALIMENTARY TRACT AND METABOLISM 43 A01 STOMATOLOGICAL PREPARATIONS 43 A02 DRUGS FOR ACID RELATED DISORDERS 44 A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS 47 A04 ANTIEMETICS AND ANTINAUSEANTS 48 A05 BILE AND LIVER THERAPY 49 A06 LAXATIVES 51 A07 ANTIDIARRHOEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVES 52 A08 ANTIOBESITY PREPARATIONS EXCLUDING DIET PRODUCTS 54 A09 DIGESTIVES INCLUDING ENZYMES 55 39 A10 ANTIDIABETIC THERAPY 56 A11 VITAMINS 59 A12 MINERAL SUPPLEMENTS 60 A14 ANABOLIC AGENTS FOR SYSTEMIC USE 61 BLOOD AND BLOOD FORMING ORGANS 62 B01 ANTITHROMBOTIC AGENTS 62 B02 ANTIHAEMORRHAGICS 64 B03 ANTIANAEMIC PREPARATIONS 65 B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS 67 B06 OTHER HAEMATOLOGICAL AGENTS 68 CARDIOVASCULAR SYSTEM 69 C01 CARDIAC THERAPY 69 C02 ANTIHYPERTENSIVES 71 C03 DIURETICS 72 C04 PERIPHERAL VASODILATORS 73 C05 VASOPROTECTIVES 74 C07 BETA BLOCKING AGENTS 75 C08 CALCIUM CHANNEL BLOCKERS 76 C09 AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM 77 C10 LIPID MODIFYING AGENTS PLAIN 81 DERMATOLOGICALS 83 D01 ANTIFUNGALS FOR DERMATOLOGICAL USE 83 D02 EMOLLIENTS AND PROTECTIVES 85 D03 PREPARATIONS FOR TREATMENT OF WOUNDS & ULCERS 86 D04 ANTIPRURITICS, INCLUDING ANTIHISTAMINES, ANAESTHETICS ETC 87 D05 ANTIPSORIATICS 88 D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE 89 D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS 90 D08 ANTISEPTICS AND DISINFECTANTS 92 D09 MEDICATED DRESSINGS 93 D10 ANTI-ACNE PREPARATIONS 94 D11 OTHER DERMATOLOGICAL PREPARATIONS 95 40 GENITO URINARY SYSTEM AND SEX HORMONES 96 G01 GYNAECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS 96 G02 OTHER GYNAECOLOGICALS 97 G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM 98 G04 UROLOGICALS 104 SYSTEMIC HORMONAL preparations, excluding sex hormones 106 H01 PITUITARY, HYPOTHALAMIC HORMONES AND ANALOGUES 106 H02 CORTICOSTEROIDS FOR SYSTEMIC USE 107 H03 THYROID THERAPY 108 H04 PANCREATIC HORMONES 109 H05 CALCIUM HOMEOSTASIS 110 GENERAL ANTIINFECTIVES FOR SYSTEMIC USE 111 J01 ANTIBACTERIALS FOR SYSTEMIC USE 111 J02 ANTIMYCOTICS FOR SYSTEMIC USE 117 J04 ANTIMYCOBACTERIALS 118 J05 ANTIVIRALS FOR SYSTEMIC USE 119 J07 VACCINES 121 ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS 123 L01 ANTINEOPLASTIC AGENTS 123 L02 ENDOCRINE THERAPY 132 L03 IMMUNOSTIMULANTS 134 L04 IMMUNOSUPPRESSANTS 135 MUSCULO-SKELETAL SYSTEM 139 M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS 139 M02 TOPICAL PRODUCTS FOR JOINT and MUSCULAR PAIN 142 M03 MUSCLE RELAXANTS 143 M04 ANTIGOUT PREPARATIONS 144 M05 DRUGS FOR TREATMENT OF BONE DISEASES 145 NERVOUS SYSTEM 147 N01 ANAESTHETICS 147 N02 ANALGESICS 148 N03 ANTIEPILEPTICS 154 41 N04 ANTI-PARKINSON DRUGS 157 N05 PSYCHOLEPTICS 159 N06 PSYCHOANALEPTICS 167 N07 OTHER NERVOUS SYSTEM DRUGS 168 ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS 170 P01 ANTIPROTOZOALS 170 P02 ANTHELMINTICS 171 P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS 172 RESPIRATORY SYSTEM 173 R01 NASAL PREPARATIONS 173 R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES 176 R05 COUGH AND COLD PREPARATIONS 179 R06 ANTIHISTAMINES FOR SYSTEMIC USE 180 SENSORY ORGANS 183 S01 OPHTHALMOLOGICALS 183 S02 OTOLOGICALS 189 S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS 190 VARIOUS 191 V01 ALLERGENS 191 V03 ALL OTHER THERAPEUTIC PRODUCTS 192 42 A 2009 ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($) ALIMENTARY TRACT AND METABOLISM STOMATOLOGICAL PREPARATIONS STOMATOLOGICAL PREPARATIONS ANTIINFECTIVES FOR LOCAL ORAL TREATMENT A01AB04 AMPHOTERICIN P 2931G Lozenge 10mg 40.00 MG 148,476 1,673,934 P 3306B Lozenge 10mg 40.00 MG 4,226 46,083 A01AB03 CHLORHEXIDINE P 4161B Mouth wash 2mg per mL (0.2%) 250mL 30.00 MG 2,263 29,395 A01AB09 MICONAZOLE A 13832 Oral gel 20mg per mL (2%) 20g 0.20 GM 2,875 – A 14054 Oral gel 40mg per mL (2%) 40g 0.20 GM 1,419 – A01AB11 NYSTATIN P 3033P Oral suspension 100,000 units per mL 24mL 1500.00 TE 141,637 1,531,560 P 3343Y Oral suspension 100,000 units per mL 24mL 1500.00 TE 967 10,308 CORTICOSTEROIDS FOR LOCAL ORAL TREATMENT A01AC01 TRIAMCINOLONE ACETONIDE with PECTIN A 11075 Paste 1% 5gm – – 11,416 – OTHER AGENTS FOR LOCAL ORAL TREATMENT A01AD02 BENZYDAMINE HYDROCHLORIDE P 1121B Mouth and throat rinse 22.5mg per 15mL 500mL – – 4,529 95,722 P 5032W Mouth and throat rinse 22.5mg per 15mL 500mL – – 264 5,836 P 5385K Mouth and throat rinse 22.5mg per 15mL 500mL – – 148 4,041 A01AD11 CHOLINE SALICYLATE with CETALKONIUM CHLORIDE A 12855 Gel 10g 1 – – 980 – A01AD11 SALIVA SUBSTITUTE P 4568K Solution 25mL – – 530 5,590 P 4569L Solution 100mL – – 616 9,016 A01AD11 VARIOUS P 5334R Spray 10mg per mL 100mL – – 276 3,625 43 A 2009 ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($) ALIMENTARY TRACT AND METABOLISM DRUGS FOR ACID RELATED DISORDERS ANTACIDS ALUMINIUM COMPOUNDS A02AB01 ALUMINIUM HYDROXIDE A 10038 Tablet 600mg 100 – – 1,421 – CALCIUM COMPOUNDS A02AC10 CALCIUM CARBONATE with GLYCINE P 4055K Tablet 420mg-180mg – – 330 7,575 COMBS.AND COMPLEXES OF ALUMINIUM,CALCIUM AND MAGNESIUM COMPOUNDS A02AD ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE P 2157M Oral suspension 200mg-200mg per 5mL 500mL – – 86,625 1,354,768 P 2576N Tablet 200mg-200mg – – 4,491 69,139 P 4118R Oral suspension 400mg-400mg-30mg per 5mL – – 2,373 51,757 A02AD ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE with SIMETHICONE A 20644 Chewable tablet 200mg-200mg-20mg 100 – – 1,724 – P 4453J Tablet 400mg-400mg-40mg 200 – – 2,157 98,008 A02AD ALUMINIUM HYDROXIDE with MAGNESIUM TRISILICATE and MAGNESIUM HYDROXIDE P 2159P Oral suspension 250mg-120mg-120mg per 5mL – – 19,420 272,155 DRUGS FOR PEPTIC ULCER AND GORD H2-RECEPTOR ANTAGONISTS A02BA01 CIMETIDINE P 1157X Tablet 200mg 0.80 GM 2,900 56,780 P 1158Y Tablet 400mg 0.80 GM 23,482 463,386 P 1159B Tablet 800mg 0.80 GM 1,416 28,974 A02BA03 FAMOTIDINE P 2487X Tablet 20mg 40.00 MG 51,002 877,259 P 2488Y Tablet 40mg 40.00 MG 60,216 1,097,834 A02BA04 NIZATIDINE P 1504E Capsules 300mg 30 0.30 GM 53,064 1,026,773 P 1505F Capsules 150mg 30 0.30 GM 78,120 1,472,028 A02BA02 RANITIDINE HYDROCHLORIDE P 1937Y Effervescent tablet 150mg (base) 0.30 GM 44,103 777,639 P 1977C Tablet 300mg (base) 0.30 GM 262,784 4,752,368 P 1978D Tablet 150mg (base) 0.30 GM 631,192 11,086,977 P 8162N Syrup 150mg (base) per 10mL 300mL 0.30 GM 22,686 443,413 P 8903N Effervescent tablet 150mg (base) 0.30 GM 1,524 33,658 P 8905Q Syrup 150mg (base) per 10mL 300mL 0.30 GM 403 10,445 PROSTAGLANDINS A02BB01 MISOPROSTOL P 1648R Tablet 200ug 0.80 MG 2,197 114,126 44 A 2009 ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($) ALIMENTARY TRACT AND METABOLISM DRUGS FOR ACID RELATED DISORDERS DRUGS FOR PEPTIC ULCER AND GORD PROTON PUMP INHIBITORS A02BC05 ESOMEPRAZOLE A 20665 Sachet granules 10mg 30 30.00 MG 467 – P 8600P Tablet 20mg (enteric coated) 30 30.00 MG 3,529,319 135,209,501 P 8601Q Tablet 40mg (enteric coated) 30 30.00 MG 2,489,498 145,425,157 P 8886Q Tablet 20mg (enteric coated) 30 30.00 MG 118,775 4,537,761 A02BC03 LANSOPRAZOLE P 2240X Capsule 30mg 28 30.00 MG 15,749 584,969 P 2241Y Capsule 30mg 28 30.00 MG 536,295 21,898,955 P 8198L Capsule 15mg 28 30.00 MG 21,162 516,359 P 8528W Sachet for oral suspension 30mg 28 30.00 MG 1,988 76,112 P 8529X Sachet for oral suspension 30mg 28 30.00 MG 13,718 549,502 P 8950C Sachet for oral suspension 30mg 28 30.00 MG 1,204 63,035 P 9477T Tablet 30mg (orally disintegrating) 28 30.00 MG 6,364 221,277 P 9478W Tablet 30mg (orally disintegrating) 28 30.00 MG 133,734 4,984,904 A02BC01 OMEPRAZOLE P 1326T Capsule 20mg 20.00 MG 11,633 310,484 P 1327W Capsule 20mg 20.00 MG 210,962 7,206,700 P 8331L Tablet 20mg (as magnesium salt) 30 20.00 MG 27,412 716,722 P 8332M Tablet 10mg (as magnesium salt) 30 20.00 MG 69,641 1,621,998 P 8333N Tablet 20mg (as magnesium salt) 30 20.00 MG 535,721 15,892,005 P 9109K Tablet 20mg (as magnesium salt) 30 20.00 MG 60,020 1,738,374 P 9110L Tablet 20mg (as magnesium salt) 30 20.00 MG 2,474,496 84,951,426 A02BC02 PANTOPRAZOLE A 20488 Tablet (enteric coated) equivalent to 20mg 7 40.00 MG 731 – A 20489 Tablet (enteric coated) equivalent to 20mg 14 40.00 MG 1,050 – P 8007K Tablet (enteric coated) equivalent to 40mg 40.00 MG 364,728 14,040,532 P 8008L Tablet (enteric coated) equivalent to 40mg 40.00 MG 3,117,108 129,542,996 P 8399C Tablet (enteric coated) equivalent to 20mg 40.00 MG 392,540 8,858,096 P 9423Y Sachet containing granules